AI and Stem Cells to Take Center Stage at Israel's Leading Medical Innovation Conference
Lema'anchem's third annual medical conference will convene on November 10 at Reichman University in Herzliya. The focus: stem cells, artificial intelligence, and how these tools can move care from theory to practice.
The event opens with remarks from President Isaac Herzog and is expected to draw more than 800 participants across medicine, research, and tech. Expect a practical lens on what's workable in clinics and labs within the next few years.
Why this matters for healthcare leaders
Regenerative medicine is moving fast from lab insights to clinical protocols. Sessions will cover tissue and organ repair, individualized care plans based on DNA, and AI methods that can predict cell growth and improve therapy design.
- Modeling cell behavior to speed preclinical decisions and reduce trial-and-error.
- Patient-specific treatment approaches informed by genomics and clinical history.
- More precise targeting of therapies, with clearer endpoints and better stratification.
Speakers and hosts
The conference is hosted by Prof. Uriel Reichman, founding president and chairman of Reichman University, and emceed by Guy Zo-Aretz. Featured speakers bring leadership experience across health systems, academia, and research institutes.
- Prof. Ran Balicer, Chief Innovation Officer, Clalit Health Services (Clalit)
- Maj. Gen. (res.) Yochanan Locker, Chairperson, Clalit
- Prof. Eli Sprecher, CEO, Tel Aviv Sourasky Medical Center
- Prof. Jacob Hanna, Weizmann Institute of Science (Weizmann Institute)
- Prof. Eran Meshorer, Hebrew University
- Prof. Ayal Hendel, Bar-Ilan University
- Prof. Irit Avivi, Head, Division of Hematology, Sourasky
What the program covers
- Regenerative medicine: practical advances in tissue and organ repair.
- Individualized treatments based on patients' DNA and clinical profiles.
- AI in the cell and gene therapy pipeline: predicting cell growth, designing targeted therapies, and configuring treatment systems for individual patients.
Who's behind it
The initiative is led by Lema'anchem founder and chair Yossi Erblich. The leadership team includes Prof. Yosef Press (president), Dr. Gadi Neuman (innovation division), and conference president Baruch Scheinberg.
Partners include Reichman University, Prof. Reichman, and Prof. Arnon Afek, dean of the Dina Recanati School of Medicine. Lema'anchem provides free daily medical guidance and professional support to thousands of patients across Israel, operating on a volunteer basis to advance care, research, and the link between science and society.
For attendees: quick prep
- List 2-3 use cases where AI or stem-cell therapies could change outcomes in your department (e.g., hematology, oncology, wound care).
- Bring current protocols and real de-identified cases to pressure-test with peers and researchers.
- Clarify regulatory and data needs early: consent, data quality, model validation, and safety monitoring.
- Identify partners for pilots: hospital innovation teams, HMOs, and academic labs represented at the event.
If your team is building AI literacy ahead of the conference, you can explore role-based learning paths here: Complete AI Training: Courses by Job.
Your membership also unlocks:
